Lupus Foundation of America52 分钟
Investigator-initiated Study of CNTY-101, for People with Autoimmune Diseases, Including ...
An investigator-initiated Phase 1/2 trial of CNTY-101, an investigational therapy, has been announced for the treatment of ...